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The leptomeninges, consisted of pia mater and arachnoid, cover the surface of brain parenchyma. Leptomeningeal cells 
produce a number of biologically active proteins, including prostaglandin-D synthase, cyclooxygenase-1, -2, insulin-like growth 
factor-II, insulin-like growth factor-binding proten-2, andapolipoproteinE, released into the cerebrospinal fluid. The involvement of 
leptomeninges in neurotrophic, scavenging, and transport activities as well as inflammatory responses, associated with the brain, 
is reviewed. Biomed Rev 1999; 10: 31-36. 
INTRODUCTION 
The leptomeninges are a connective tissue compartment 
composed of pia mater and arachnoid. The adventitial 
leptomeninges surrounding the cerebral vessels are built up of 
collagen fiber bundles.Thepiamater covering the brain 
parenchyma has wide intercellular spaces with sparse and fine 
fiber bundles. This compartment is composed of a delicate but 
continuous layer of cells joined by desmosomes and nexuses. 
The trabecu-lar leptomeninges, linking arachnoid and pia mater, 
are in the subarachnoid space filled with cerebrospinal fluid 
(CSF). Generally, the border between the outer arachnoid 
layer and the neurothelium is the CSF-blood barrier. Both pia 
mater and arachnoid develop from a mesenchymal meninges 
primitiva on the telencephalic surface, and display a common 
cytologic characteristics. Accumulating physiological 
evidence supports the assumption that leptomeningeal cells are 
not merely brain-covering cells. For example, fetal brain 
neurons transplanted into the meningeal or subarachnoid space 
survive for a long time and keep on functioning (1). When 




nence of the hypophysectomized rat, many regenerating nerve 
fibers penetrate into the transplanted tissue (2). Moreover, 6-
hydroxydopamine treatment of the brain surface causes 
degeneration of leptomeningeal cells which results in an 
abnormal development of Cajal-Retzius cells (3). These 
physiological findings indicate that leptomeninges secrete some 
biologically active substances that play an important roles in the 
regulation of brain functions. 
PROTEINS PRODUCED BY LEPTOMENINGES 
By immunocytochemistry and in situ hybridization methods, 
many biologically important proteins are found in 
leptomeninges. These include transforming growth factor-beta 1 
(TGF-pl) (4), prostaglandin-D synthase (beta-trace protein) (5), 
and parathyroid hormone-related protein (PTHRP) (6). 
Likewise, insulin-line growth factor-II (IGF-II) and mRNA for 
IGF binding protein-2 (IGFBP-2) and IGFBP-4 are localized in 
leptomeninges (7-10). Transferrin and transthyretin mRNA are 
also located in this structure (11). Likewise, human laminin M 
chain (merosin) and fubulin, an extracellular matrix protein, are 
expressed in 
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leptomeninges(12,13). Leptomeninges from the normal, aged, 
and Alzheimer's disease (AD) brains contain high levels of p-
amyloid protein and p-amyloid precursor protein (14-16). In 
addition, several other proteins have been identified in medium 
conditioned with cultured leptomeningeal cells (17,18). These 
include prostaglandin-D synthase, IGFBP-2,-4, apolipoprotein E 
(apoE), beta2-microglobulin (P 2-M), cystatin C, IGF-II, des-1 -IGF-
II, secreted protein acidic and rich in cysteine, transferrin, ly 
sozyme C, peptidyl-prolyl cis-tmns isomerase (cyclophilin C), 
ubiquitin, extracellular superoxide dismutase, and collagen a-1 
(III). Figure 1 presents a schematic view of leptomeninges and 
CSF, including a selected list of leptomeninges-derived 
molecules. 
LEPTOMENINGES: A MEUROTROPHIC SURFACE 
Most of the leptomeningeal cell-derived proteins are CSF 
components. Prostaglandin-D-synthase and cystatin C are 
known to be beta-trace protein and gamma-trace protein, 
respectively, in CSF (19,20). IGF-E, the major IGF in the brain, 
is present as a complex with IGFBP-2 in CSF (21,22). ApoE and 
transferrin are also essential components of CSF (23). IGF-II is 
one of the majorneurotrophic factors in the brain. In addition,p2-
M seems to have a neurotrophic potential, mediated by p2-M-
induced collagenase synthesis (24) and stimulation of DNA 
and protein synthesis (25). Further, a diffusible substance 
secreted by leptomeningeal cells is a key chemotactic factor 
stimulating and directing the migration of cerebellar external 
granular cells (26). 
It is therefore likely that leptomeninges exert trophic action on 
neuronal and glial cells through the release of neurotrophic 
factors into CSF. Accordingly, fibroblast growth factors 
enhance nerve growth factor (NGF) secretion by fibroblasts 
derived from leptomeninges but not by microglia (27). In 
addition, chronic intraventricular infusion of recombinant 
human NGF results in axonal sprouting and glial cell hyperplasia 
in the leptomeninges (28). Furthermore, NGF-gamma, a serine 
pro-teas of the kallikrein family, is a potent IGFBP-3 protease 
(29). These data suggest that NGF may be involved in the 
growth of cells no only by binding to its receptors but is 
capable of cleaving IGFBP and thus enhancing IGF action. This 
synergis-tic action of NGF and IGF may be involved in cell 
growth and repair in the brain. Further, as indicated above, 
laminin is expressed in meningeal tissue (12), and this matrix 
protein may synergistically with NGF promote neuronal survival 
(30). 
CARRIER PROTEINS 
Several protein molecules capable to bind biologically important 
substances are produced by the leptomeninges. They 
include prostaglandin-D-synthase, IGFBP-2, IGFBP-4, apoE, 
transferrin, and transthyretin, a carrier of thyroid hormone. 
Prostaglandin-D synthase is a retinoid-binding protein (31). 
Retinoic acid synthesis by leptomeninges is comparable to rates 
found in liver (32), and cellular retinol-binding protein type-I is 
found in both leptomeninges and choroid plexus as well as the 
wall of cerebral blood vessels (33). This binding protein may 
transport retinol across the blood-CSF barrier, and hence the 
leptomeninges play an important role in the regulation of 
metabolism and/or transport of vitamin A in the brain. Further, 
apoE, a known risk factor for AD, and cholesterol carrier, has a 
high affinity for P-amyloid protein (34-36). The leptomeninges 
from both aged and AD's brains contain very high levels of P-
amyloid protein. Although the origin of such p-amyloid protein in 
the leptomeninges is suspected to be vascular muscle cells, we 
could not exclude the possibility that the insoluble p-amyloid 
protein is also derived from leptomeningeal cells themselves. 
Since the amount of soluble P-amyloid protein in the 
leptomeninges is comparable to that in the blood vessel wall 
(16), leptomeninges seem to be a large reservoir of this protein in 
aged and AD brains. In fact, human leptomeningeal cells 
implanted into the rat brain have been shown to produce a large 
amount of human P-amyloid protein as well as p-amyloid 
precursor protein (36). In canine leptomeningeal organ 
cultures, exo-genously added P-amyloid protein is focally 
deposited in the vessel walls (37). Therefore, the 
disturbance of apoE and amyloid protein metabolism in the 
leptomeninges may cause the deposition of P-amyloid protein in 
the aged and AD brain. It is also noteworthy that the abnormality 
of apo E, cystatin C, and transthyretin results in the amyloid 
deposits (11-38). Hence, one of the main roles of leptomeninges 
seems to be that of carrier of substances through the blood-CSF 
barrier. 
SCAVENGER PROTEINS 
The precise roles of most protein factors produced by 
leptomeninges are not completely understood. For instance, 
transferrin is an essential carrier of iron ion (39), but few data 
suggest its role in the process of neuronal degeneration. 
Accordingly, the distribution patterns of transferrin, apoE, 
cystatin C, p2-M, and apoE in the neurons fated to die after 
hypophysectomy or ischemia have been studied (40-42). The 
accumulation of these proteins in the injured neurons 
suggests the involvement of such carrier proteins in the 
process of neuronal degeneration. Cystatin C is a potent 
inhibitor of cysteine proteases, such as cathepsins. Cathepsins 
in neurons are activated during the early stages of ischemia (43), 
suggesting a possibility that cystatin C may form a complex with 
such proteases derived from injured neurons. As indicated 
above, apoE binds cholesterol released from injured neurons. 
The cholesterol, combined with apoE, may be reutilized by 
regenerating neurons through a receptor-mediated uptake. 
Soluble P2-M not accumulate in the atrophied CA1 
neurons after ischemia, but intensive accumulation of this 
protein appears in the vasopressin-positive neurons after 
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Figure 1. A schematic drawing ofleptomeningeal and cerebrospinal fluid (CSF) compartment. A selected list of leptomeninges-
derived molecules is also presented (the abbreviations are indicated in the text). 
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ischemia, parts of vasopressin neurons can regenerate their 
fibers after hypophysectomy. It is likely therefore that p2-M 
accumulated in the injured cell bodies is involved in the 
neuronal regeneration. Probably, CSF (32-M may act as a 
neurotrophic factor. Altogether, these findings may support 
the hypothesis that leptomeninges take part in scavenging the 
waste materials, especially at the border between brain and 
blood. This appears to be beneficial for the maintenance of 
brain neurons. 
INFLAMMATION 
The role of prostaglandin-D synthase, the basic product of 
cultured leptomeningeal cells, is unclear. This glycoprotein 
catalyzes the isomerization of prostaglandin H2 to prostaglan-
din D2, which has several central actions, including sleep 
induction. Intravenous or intraventricular injection of selenium 
compounds, an inhibitor of this enzyme, inhibits sleep in rats. 
Since there is no difference between day and night level and 
activity of prostaglandin-D synthase in rat CSF (44), it is 
unlikely that this enzyme directly regulates sleep behavior under 
normal condition. One possibility is that prostaglandin-D-syn-
thase is involved in the sleep induced during pathological 
conditions, such as inflammation. Specifically, leptomeninges 
contain various immune cells, including mast cells, 
macrophages, and lymphocytes (45,46), known to secrete NGF, a 
neurotrophin implicated in large number of inraiune-inflammatory 
events (this volume of Biomedical Reviews). Further, 
cyclooxygenase-1 (COX-1) and COX-2 are induced in vascular 
and peri vascular cells in the leptomeninges after inflammatory 
stimuli, such as lipopolysaccharide and cytokines, particularly, 
interleukin-lbeta (IL-113) (47,48). Such an expression of COX, 
leading to an increased prostaglandin levels, could be involved 
in brain inflammatory responses. It would be interesting as to 
whether the expression of CSF prostaglandin-D synthase could 
also be altered in response to inflammatory stimuli. Since 
IGF and IGFBP are implicated in inflammation and cell growth, 
one may try to examine whether IGFBP proteases (29,49) are 
expressed in the leptomeninges. 
RECEPTORS 
Various factors including neurotransmitters, growth factors, 
and cytokines affect the function and growth of leptomeningeal 
cells. For example, SMS 201-995, a somatostatin agonist, has an 
effect on [3H]-thymidine incorporation by meningeal cells (50). In 
addition, catecholamine-O-methyl transferase is known to be 
distributed in leptomeninges, and 6-hydroxydopamine 
treatment causes leptomeningeal degeneration, resulted in the 
disorganization of Cajor Retzius cell (3). These findings suggest 
that leptomeningeal cells can receive information from both the 
central and peripheral neurons. However, the innervation of the 
leptomeninges (except adventitial) is not intense (51). One 
explanation is that the leptomeninges receive the information 
through CSF. For example, gamma-aminobutyric acid (GAB A) 
transporter mRNA are distributed in the leptomeninges (52). 
Such transporters may help to regulate the amount of GAB A 
available to proliferating and migrating neurons at the subpial 
surface, at least during perinatal development. Intriguingly, it 
was reported that binding sites of leptin, a cytokine secreted not 
only by adipose tissue, are found in both leptomeninges and 
choroid plexus (53,54). Whether leptin may be involved in 
inflammatory processes in the leptomeninges, remains to be 
evaluated. Accordingly, IL-1 receptors are detected at high 
density in the leptomeninges (55). And injection of IL-1 into the 
brain parenchyma increases serum permeability in the 
leptomeninges, but not in the blood-brain barrier at the injection 
site 
(56). Furthermore, injection of IL-6 into the lateral ventricle 
increases the expression ofc-fos mRNA in leptomeningeal cells 
(57). 
CONCLUSION 
The leptomeninges are source of and target for a number of 
biologically active molecules which play important roles in 
neurotrophic, scavenging, and transport activities as well as 
inflammatory processes in the brain. 
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